查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1358027

活性藥物原料藥(API) 市場：依產品類型、依分子類型、按劑型、依用途、按地區

Active Pharmaceutical Ingredients Market, By Product Type, By Molecular Type, By Formulation, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 310 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球活性藥物原料藥（API）市場預計2023年將達2,350億美元，預測期內（2023-2030年）年複合成長率為6.8%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 2350億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 6.80% 2030年市場規模預測 3724億美元
活性藥物原料藥的全球市場佔有率(%)（按產品類型），2023 年
原料藥市場-IMG1

活性藥物原料藥(API) 和賦形劑是藥品製造中最重要的兩個要素。 API是用於製造藥物的原料，而賦形劑是錠劑中所含的乳糖或礦物油等物質，可作為幫助人體吸收藥物的介質。藥物原料藥是在研發階段和商業生產階段採用高科技工業製程製造的。發展其他活性以對疾病的診斷、治療、緩解、治癒或預防具有藥理活性或其他直接作用，或改變身體的結構或功能。活性藥物原料藥（API）市場的成長可歸因於某些要素，例如不同地區政府增加的資金籌措措施。例如，2020年5月，美國衛生與公眾服務部（HHS）授予了一份為期四年的契約，生產治療COVID-19及相關疾病患者的藥物所需的活性藥物原料藥（API），宣布價值3.54億美元為製藥公司 Phlow Corporation 提供資金。

市場動態

製藥公司對美國食品藥物管理局（FDA）藥品核准的增加預計將在預測期內進一步推動全球活性藥物原料藥（API）市場的成長。例如，2020年12月，美國製藥公司艾莉·禮來公司宣布將增加其2型糖尿病治療藥物Trulicity療法的劑量，增加治療轉移性腎小球濾過率（EGFR）突變非小細胞的治療藥物Cyramza的劑量肺癌，並增加被診斷為阿茲海默症的患者數量。我們的多種藥物已獲得美國FDA 批准，其中包括用於人類的 tauvid。

本研究的主要特點

  • 該報告對全球活性藥物原料藥（API）市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和平均年度（年複合成長率%）。
  • 它揭示了各個細分市場的潛在收入機會，並概述了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球活性原料藥(API) 市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場經營團隊和行銷策略做出明智的資訊。
  • 全球活性藥物原料藥(API) 市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過分析全球活性藥物原料藥(API) 市場時使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 法規場景
  • 市場趨勢
  • API專利有效期限
  • 產能分析
  • 合併、收購和合作場景
  • 主要進展
  • PEST分析
  • 投資金籌措
  • 生產消費分析

第4章 全球藥物原料藥(API) 市場 - COVID-19 疾病的影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 對需求和供給的影響

第5章 全球活性藥物原料藥（API）市場，依產品類型，2018-2030

  • 低效率 API
  • 高效API

第6章 全球活性藥物原料藥(API) 市場，依分子類型，2018-2030

  • 低分子
  • 高分子

第7章 全球活性藥物原料藥（API）市場，按劑型，2018-2030

  • 口服
  • 外用
  • 注射
  • 滴水

第8章 全球活性藥物原料藥(API) 市場，依用途，2018-2030

  • 糖尿病
  • 腫瘤學
  • 心血管
  • 中樞神經系統
  • 止痛藥
  • 眼科
  • 呼吸系統
  • 皮膚科
  • 其他

第9章 全球活性藥物原料藥（API）市場，按地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章 競爭形勢

  • 公司簡介
    • Teva Pharmaceutical Industries Ltd
    • Pfizer, Inc.
    • Dr. Reddy's Laboratories Ltd
    • Novartis AG
    • Mylan NV
    • Amneal Pharmaceuticals LLC
    • Lonza Group
    • Lupin Limited
    • Fresenius Kabi
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Glenmark Pharmaceuticals Limited
    • Sun Pharmaceutical Industries Ltd
    • Endo International plc
    • Aurobindo Pharma Limited
    • Apotex Inc.
    • Taro Pharmaceutical Industries Ltd
    • Stada Arzneimittel AG
    • Krka Pharmaceuticals
    • CordenPharma International
    • Evonik Industries AG
    • Biological E. Limited

第11章章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI738

The global active pharmaceutical ingredients market is estimated to be valued at US$ 235 Billion in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 235 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.80% 2030 Value Projection: US$ 372.4 Bn
Global Active Pharmaceutical Ingredients Market Share (%), By Product Type, 2023
Active Pharmaceutical Ingredients Market - IMG1

Active pharmaceutical ingredients (APIs) and excipients are the two most important components in the production of a medication. API is the raw material that is used in manufacturing medications, whereas an excipient is a substance that functions as a medium to help the body absorb the drug, such as lactose or mineral oil in a tablet. Active pharmaceutical ingredients are produced by using highly technological industrial processes, both during the research and development and commercial production phases. Such compounds are developed to provide pharmacological activity or other direct impacts on disease diagnosis, cure, mitigation, therapy, or prevention, or to change the structure and function of the body. The growth of the active pharmaceutical ingredients (API) market can be attributed to certain factors, such as increasing funding initiatives by the government across different regions. For instance, in May 2020, the U.S. Department of Health and Human Services (HHS) announced that it will provide funding of US$ 354 million to Phlow Corporation, a pharmaceutical company, under a four-year contract to produce the active pharmaceutical ingredientss (APIs) needed for medications to treat patients with COVID-19 and related illnesses.

Market Dynamics

The rising U.S. Food and Drug Administration (FDA) approvals for drugs by pharmaceutical companies are further expected to boost the global active pharmaceutical ingredients (API) market growth during the forecast period. For instance, in December 2020, Eily Lilly, an American pharmaceutical company received U.S FDA clearance for several medicines, including increased dosages of its Trulicity therapy for the treatment of type 2 diabetes, Cyramza for the treatment of metastatic Estimated Glomerular Filteration Rate (EGFR)-mutated non-small cell lung cancer, and tauvid for individuals diagnosed with Alzheimer's disease.

Key features of the study:

  • This report provides an in-depth analysis of the global active pharmaceutical ingredients (API) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global active pharmaceutical ingredients (API) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Dr. Reddy's Laboratories Ltd., Novartis AG, Mylan N.V., Amneal Pharmaceuticals LLC, Lonza Group, Lupin Limited, Fresenius Kabi, Hikma Pharmaceuticals, Cipla Limited, Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Endo International plc, Aurobindo Pharma Limited, Apotex Inc, Taro Pharmaceutical Industries Ltd, Stada Arzneimittel AG, Krka Pharmaceuticals, CordenPharma International, Evonik Industries AG, and Biological E. Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global active pharmaceutical ingredients (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global active pharmaceutical ingredients (API) market.

Active Pharmaceutical Ingredients (API) Market Detailed Segmentation:

  • By Product Type:
    • Low Potent APIs
    • High Potent APIs
  • By Molecular Type:
    • Small Molecules
    • Large Molecules
  • By Formulation:
    • Oral
    • Topical
    • Injectables
    • Drops
  • By Application:
    • Diabetes
    • Oncology
    • Cardiovascular
    • CNS
    • Analgesics
    • Ophthalmic
    • Respiratory
    • Dermatology
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd
    • Pfizer, Inc.
    • Reddy's Laboratories Ltd
    • Novartis AG
    • Mylan N.V.
    • Amneal Pharmaceuticals LLC
    • Lonza Group
    • Lupin Limited
    • Fresenius Kabi
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Glenmark Pharmaceuticals Limited
    • Sun Pharmaceutical Industries Ltd
    • Reddy's Laboratories Ltd
    • Endo International plc
    • Aurobindo Pharma Limited
    • Apotex Inc.
    • Taro Pharmaceutical Industries Ltd
    • Stada Arzneimittel AG
    • Krka Pharmaceuticals
    • CordenPharma International
    • Evonik Industries AG
    • Biological E. Limited

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Molecular Type
    • Market Snippet, By Formulation
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Regulatory Scenario
  • Market Trends
  • API Patent Expiration
  • Production Capability Analysis
  • Mergers, Acquisitions and Collaboration Scenario
  • Key Developments
  • PEST Analysis
  • Investments & Funding
  • Production and Consumption Analysis

4. Global Active Pharmaceutical Ingredients (API) Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Active Pharmaceutical Ingredients (API) Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Low Potent APIs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • High Potent APIs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Active Pharmaceutical Ingredients (API) Market, By Molecular Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Small Molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Large Molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Injectables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • CNS
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Ophthalmic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Respiratory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

9. Global Active Pharmaceutical Ingredients (API) Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Teva Pharmaceutical Industries Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Pfizer, Inc.
    • Dr. Reddy's Laboratories Ltd
    • Novartis AG
    • Mylan N.V.
    • Amneal Pharmaceuticals LLC
    • Lonza Group
    • Lupin Limited
    • Fresenius Kabi
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Glenmark Pharmaceuticals Limited
    • Sun Pharmaceutical Industries Ltd
    • Endo International plc
    • Aurobindo Pharma Limited
    • Apotex Inc.
    • Taro Pharmaceutical Industries Ltd
    • Stada Arzneimittel AG
    • Krka Pharmaceuticals
    • CordenPharma International
    • Evonik Industries AG
    • Biological E. Limited

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact